Top 25 Cardiac Diabetic PCD Pharma Companies in India-Looking for the best cardiac and diabetic PCD pharma companies in India to expand your business or start a profitable franchise? With the increase in cases of heart disease and diabetes, the demand for cardiac and diabetic medicines in India is growing fast. Cardiac drugs like amlodipine and atenolol have seen sales increase 50% in five years, while diabetes drugs like metformin and glimepiride grew 55% in two years.
India has about 90 million diabetes patients, creating a strong opportunity for PCD pharma companies in this segment. Partnering with a trusted PCD pharma company ensures high-quality cardiac and diabetic medicines, monopoly rights, marketing support, and timely deliveries. We have created a list of the top 25 cardiac diabetic PCD pharma companies in India. Known for their quality, innovation, and trusted market presence, they are perfect for distributors, franchise partners, and healthcare professionals.
Best 25 Cardiac & Diabetic PCD Pharma Companies in India
| Company Name |
Popular Segment |
Highlight Feature |
| Nexiwn Pharma |
General & Cardiac Range |
Reliable and consistent formulations |
| Sun Pharmaceutical Industries Ltd. |
Cardiology, Neuro, Oncology |
One of India’s leading pharma giants |
| Dr. Reddy’s Laboratories Ltd. |
Generics & APIs |
Strong global research presence |
| Cipla Ltd. |
Respiratory & Cardiac Care |
Known for quality and affordability |
| Lupin Ltd. |
Cardiology & Diabetes |
Wide range of specialty medicines |
| Cardiatic Care |
Cardiovascular Products |
Dedicated healthcare solutions |
| Zyliglife Sciences |
Cardio & General Range |
Growing brand in the pharma sector |
| Torrent Pharmaceuticals |
Cardiology & CNS |
Strong position in the Indian pharma market |
| Henin Lukinz |
Cardiac & Wellness |
Emerging pharma marketing company |
| Bendic Healthcare |
General & Specialty Range |
Strong distribution network |
Nexwin Pharma PVT. LTD.
Nexwin Pharma PVT. LTD. stands out among the top 25 cardiac & diabetic PCD pharma companies in India. It is known for providing a 1000+ product portfolio dedicated to the Cardiac & Diabetic Care range, and all products are DCGI approved. Nexiwn offers multiple disease forms, including tablets, softgels, injectables, sachets, syrups, protein powders, and respules, giving the franchise partners a wider market range. All products are manufactured under a strict quality standard and are backed by WHO-GMP certification, ensuring safety and effectiveness.
| Key Facts |
Details |
| Industry Experience |
30 Years of Excellence in the Pharmaceutical Industry |
| Customer Satisfaction |
100% Customer Satisfaction |
| Specialized Divisions |
12+ Divisions Catering to Diverse Healthcare Needs |
| Expert Workforce |
70+ Highly Skilled Professionals Driving Growth & Quality |
| Quality Certification |
Globally Recognized WHO-GMP Certification |
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd. is recognized as a leading diabetic PCD pharma company in India due to its strong global presence, research, and specialty medicine. Sun Pharma operates in over 100 countries with 40+ manufacturing facilities. The company has a large portfolio, including a dedicated cardiac and diabetic care range, as well as medicines for oncology, dermatology, neuropsychiatry, and gastroenterology, and all products are manufactured under high-quality standards and WHO-GMP certification. They keep focusing on R&D, new drug development, biologics, and complex generics.
| Key Facts |
Inshight |
| Products |
2000+ formulations |
| Employees |
38,000+ worldwide |
| R&D Centers |
6 state-of-the-art research facilities |
| TVCs & Corporate Films |
5+ major campaigns highlighting patient impact |
| Awards & Recognitions |
20+ national & international awards |
Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. is a trusted name among cardiac and diabetic PCD pharma companies in India. The company is developing and manufacturing high-quality cardiac and diabetic medicines, including tablets, injectables, and specialty formulations. Dr. Reddy’s operates in 83 countries globally, and the company ensures safe, effective, and accessible treatment worldwide. Dr. Reddy’s commitment to quality, innovation, and patient support positions it as a trusted choice among distributors and partners in the expanding cardiac and diabetic pharmaceutical market.
| Key Facts |
Details |
| US ANDAs |
299 active Abbreviated New Drug Applications |
| US DMFs |
264 active Drug Master Files |
| EU Dossiers Filed |
166 active dossiers |
| EU DMFs |
121 active Drug Master Files |
| Patients Reached |
~756 million (FY’25) |
Cipla Ltd.
Cipla Ltd. is one of the best cardiac & diabetic pharma franchise companies in India, known for its broad range of medicines. The company supports franchise partners with a high-quality 1500+ product portfolio covering cardiac and diabetic care, along with other therapeutic areas. Cipla ensures all the products are manufactured in WHO-GMP-compliant manufacturing and are DCGI-approved products, ensuring safety, quality, and effectiveness, making Cipla a trusted choice in the growing cardiac and diabetic pharmaceutical segment in India.
| Key Facts |
Figures |
| Manufacturing Sites |
46 |
| Dosage Forms |
50+ |
| Countries / Markets |
74 |
| Years of Operation |
90+ years (founded in 1935) |
| Global Presence |
Australia, Brazil, Europe, Germany, Ghana, Kenya, Malaysia, Morocco, Nepal, South Africa, Spain, Sri Lanka, Uganda, the UK, and the USA |
Lupin Ltd.
Lupin Ltd, India’s top PCD pharma company for cardiac and diabetic care, was established in 1968. The company is offering a wide portfolio of medicines for cardiac and diabetic care, alongside complex generics, specialty formulations, and branded products. Lupin is operating in over 100 countries and has strong R&D and manufacturing capabilities. The company ensures that all the products manufactured are DCGI-approved and WHO-GMP compliant.
| Key Facts |
Details |
| Global Facilities |
40+ facilities worldwide |
| Employees |
20,000+ worldwide |
| Products |
1,500+ formulations |
| Sustainability Ranking |
S&P Global ESG Score 91—World No. 1 in pharma sustainability |
Cardiatic Care
Cardiatic Care is known as the top cardiac & diabetic PCD medicine manufacturer in India. The company is offering high-quality cardiovascular and diabetes medicines and a wide range of products. All the products are manufactured under WHO-GMP certified standards and are DCGI approved. Cardiatic Care provides exclusive monopoly-based franchise opportunities, attractive profit margins, and strong promotional support to its business partners.
| Key Facts |
Details |
| Total Products |
100+ DCGI & FSSAI-approved cardiac & diabetic medicines |
| Certifications |
ISO 9001:2015, WHO & GMP compliant |
| Manufacturing Facility |
Large-scale industrial plant, divided into multiple specialized sections |
| Franchise & Distribution |
Pan-India coverage with timely delivery and reliable inventory |
| Incentives & Marketing Support |
Attractive rewards, promotional materials, product brochures, MR bags, samples |
Zylig Lifesciences
Zylig Lifesciences is a trusted cardiac and diabetic pharma franchise company in India, known for delivering a high quality medicine. The company has over 30 years of experience and offers a wide range of 500+ pharma products. Zylig specializes in cardiac care, diabetes management, dermatology, neurology, and other therapeutic segments. They also provide monopoly-based PCD pharma franchise opportunities, ensuring that the franchise partners enjoy the marketing support. Zylig Lifesciences offers third-party manufacturing and export services.
| Key Facts |
Data |
| Clients |
1000+ satisfied customers |
| Partners |
200+ franchise & distribution partners |
| Certifications |
ISO, GMP, WHO certified |
| Third-Party Manufacturing |
Available for domestic & global markets |
| Export Presence |
Active exporter to multiple countries |
Torrent Pharmaceuticals
Torrent Pharmaceuticals is a leading cardiac and diabetic PCD pharma company in India. The company is offering a wide range of high-quality medicines that meet WHO and GMP standards. They manufactured their product in advanced manufacturing facilities and have a skilled R&D team. Its global presence across 50+ countries, including the US, UK, Germany, Brazil, and Europe, makes it a trusted name in cardiac and diabetic pharmaceutical solutions.
| Key Facts |
Details |
| Annual Turnover |
₹11,500+ crore (FY2025) |
| Manufacturing Facilities |
8 advanced plants across India |
| Scientists & Researchers |
800+ highly skilled professionals |
| Global Product Registrations |
2000+ approved medicines |
| Market Leadership |
Largest market share among Indian pharma companies in Brazil and Germany |
Henin Lukinz Pvt. Ltd.
Henin Lukinz Pvt. Ltd., based in Chandigarh, is one of the top 10 cardiac and diabetic PCD pharma companies. The company is known for providing a wide product range, including cardiac, diabetic, pediatric, injectable, and other therapeutic medicines. They are also offering exclusive PCD pharma franchise opportunities and contract manufacturing. Henin Lukinz is an ISO 9001:2008 certified company having advanced packaging techniques, and timely delivery makes Henin Lukinz Pvt. Ltd. a preferred partner for healthcare professionals and business associates across India.
| Key Facts |
Details |
| Years of Operation |
7 Years |
| Total Products |
200+ products (including API & Chemicals) |
| Clients Served |
200+ Pharma Companies (API & Chemicals) |
| Quality Compliance |
GMP adherence, WHO norms followed |
| Manufacturing Capacity |
High-volume production for multiple therapeutic segments |
Bendic Healthcare Pvt. Ltd
Bendic Healthcare Pvt. Ltd. is a well‑established cardiac and diabetic PCD pharma company in India. It is known for producing a high-quality medicine and reliable franchise opportunities. The company is offering a wide range of products, including tablets, capsules, injectables, syrups, sachets, and pediatric ranges, with its portfolio also covering the cardiac and diabetic care segment. Bendic Healthcare manufactures products by following a strict quality standard and operates with ISO, WHO, and GMP certifications, ensuring that products are safe and effective.
| Key Facts |
Details |
| Business Models Offered |
PCD Franchise / Distribution / Pharma Supplier / Third‑Party Manufacturing |
| Total Product Portfolio |
350+ pharmaceutical products |
| Therapeutic Categories Covered |
Cardiac & Diabetic, Neurology, Derma, Ophthalmic, Pediatric, Antibiotics, Nutraceuticals, Tablets, Capsules, Syrups, Injectables, Softgels |
| Franchise Associate Count |
200+ associates connected throughout India |
| Market Reach |
Pan India with expanding presence in uncovered regions |
Additional Cardiac Diabetic PCD Pharma Companies in India
| Company Name |
Established Year |
Key Benefits |
| Rednirus Cardiocare |
2012 |
Monopoly rights, high-quality cardiac & diabetic medicines, strong marketing support |
| Monark Biocare |
2010 |
ISO & GMP certified, timely delivery, robust R&D support |
| Saphnix Life Care |
2013 |
Experienced team, WHO-approved formulations, reliable franchise support |
| Biocorp Lifesciences |
2008 |
Wide product portfolio, quality assurance, ethical business practices |
| Oidrac Remedies |
2011 |
Fast-growing, exclusive franchise opportunities, regulatory compliance |
| Diacare Lifesciences |
2014 |
Transparent business dealings, attractive profit margins, stock availability |
| Novacardio Biotech |
2015 |
Monopoly rights, marketing assistance, high-quality formulations |
| Healthway Pharma |
2009 |
ISO-certified, timely logistics, strong technical support |
| Cardiomax Lifesciences |
2012 |
WHO-certified, patient-centric approach, robust supply chain |
| Diabetix Pharma |
2013 |
Exclusive franchise, GMP-compliant, reliable customer support |
| Lifecare Biotech |
2010 |
Monopoly-based business model, prompt delivery, marketing support |
| QndQ Cardia |
2011 |
High-quality formulations, experienced team, ethical practices |
| Farlex Critical Care |
2014 |
ISO & GMP certified, franchise-friendly policies, stock availability |
| Loban Pharma |
2012 |
Monopoly rights, reliable supply chain, strong franchise network |
| Biorika Healthcare |
2015 |
WHO-approved medicines, marketing assistance, timely delivery |
